DE60226140D1 - Verfahren zur verkapselung eines wirkstoffs - Google Patents

Verfahren zur verkapselung eines wirkstoffs

Info

Publication number
DE60226140D1
DE60226140D1 DE60226140T DE60226140T DE60226140D1 DE 60226140 D1 DE60226140 D1 DE 60226140D1 DE 60226140 T DE60226140 T DE 60226140T DE 60226140 T DE60226140 T DE 60226140T DE 60226140 D1 DE60226140 D1 DE 60226140D1
Authority
DE
Germany
Prior art keywords
active substance
inter
coating
product
seculation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60226140T
Other languages
English (en)
Other versions
DE60226140T2 (de
Inventor
Francis Sean Moolman
Heidi Rolfes
Der Merwe Thilo Lothar Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council for Scientific and Industrial Research CSIR
Original Assignee
Council for Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25589180&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60226140(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Council for Scientific and Industrial Research CSIR filed Critical Council for Scientific and Industrial Research CSIR
Publication of DE60226140D1 publication Critical patent/DE60226140D1/de
Application granted granted Critical
Publication of DE60226140T2 publication Critical patent/DE60226140T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Medicinal Preparation (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Paints Or Removers (AREA)
DE60226140T 2001-05-30 2002-05-28 Verfahren zur verkapselung eines wirkstoffs Expired - Lifetime DE60226140T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ZA200104451 2001-05-30
ZA200104451 2001-05-30
PCT/IB2002/001853 WO2003013478A2 (en) 2001-05-30 2002-05-28 Method of encapsulating an active substance

Publications (2)

Publication Number Publication Date
DE60226140D1 true DE60226140D1 (de) 2008-05-29
DE60226140T2 DE60226140T2 (de) 2009-05-07

Family

ID=25589180

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10296849T Ceased DE10296849T5 (de) 2001-05-30 2002-05-28 Verfahren zur Einkapselung eines Wirkstoffes
DE60226140T Expired - Lifetime DE60226140T2 (de) 2001-05-30 2002-05-28 Verfahren zur verkapselung eines wirkstoffs

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10296849T Ceased DE10296849T5 (de) 2001-05-30 2002-05-28 Verfahren zur Einkapselung eines Wirkstoffes

Country Status (21)

Country Link
US (1) US7641917B2 (de)
EP (1) EP1401404B1 (de)
JP (1) JP4313196B2 (de)
CN (1) CN1255099C (de)
AT (1) ATE392203T1 (de)
AU (1) AU2002310567B2 (de)
BR (1) BR0210000A (de)
CA (1) CA2455208C (de)
CH (1) CH695418A5 (de)
CY (1) CY1108199T1 (de)
DE (2) DE10296849T5 (de)
DK (1) DK1401404T3 (de)
ES (1) ES2305250T3 (de)
FR (1) FR2825292B1 (de)
GB (1) GB2392619B (de)
HK (1) HK1066488A1 (de)
IT (1) ITMI20021169A1 (de)
NL (1) NL1020706C2 (de)
PT (1) PT1401404E (de)
WO (1) WO2003013478A2 (de)
ZA (1) ZA200309983B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002310567B2 (en) 2001-05-30 2005-10-20 Csir Method of encapsulating an active substance
US7903319B2 (en) * 2006-07-11 2011-03-08 E Ink Corporation Electrophoretic medium and display with improved image stability
US20080082764A1 (en) * 2006-10-03 2008-04-03 Yi Feng Jang Memory accessing system and method
GB0812742D0 (en) * 2008-07-11 2008-08-20 Critical Pharmaceuticals Ltd Process
GB201317756D0 (en) 2013-10-08 2013-11-20 Critical Pharmaceuticals Ltd New process
DE102018210030A1 (de) * 2018-06-20 2019-12-24 Thyssenkrupp Ag Verwendung und Recyclieren von überkritischen CO2 als Lösungsmittel für PLA und weitere biologisch abbaubaren Polymere in das Beschichtungsverfahren für Düngemittel
IT201800007993A1 (it) * 2018-08-09 2020-02-09 Greenbone Ortho Srl Impianto finalizzato alla trasformazione chimica di materiali nello stato 3d
CN112812355B (zh) * 2020-12-31 2022-09-23 厦门天生爱科技有限公司 一种具有缓释挥发性中草药有效成分的功能高分子发泡材料、制备方法和用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8500121D0 (en) 1985-01-03 1985-02-13 Connaught Lab Microencapsulation of living cells
ES2043640T3 (es) * 1987-12-21 1994-01-01 Union Carbide Corp Fluidos supercriticos como diluyentes en la aplicacion por rociada liquida de revestimientos.
EP0706821A1 (de) * 1994-10-06 1996-04-17 Centre De Microencapsulation Verfahren zum Beschichten von Partikeln
US5939485A (en) * 1995-06-19 1999-08-17 Medlogic Global Corporation Responsive polymer networks and methods of their use
WO1997006787A2 (en) * 1995-08-17 1997-02-27 Dyer, Alison, Margaret Controlled release products
FR2753639B1 (fr) * 1996-09-25 1998-12-11 Procede de preparation de microcapsules de matieres actives enrobees par un polymere et nouvelles microcapsules notamment obtenues selon le procede
US5766637A (en) * 1996-10-08 1998-06-16 University Of Delaware Microencapsulation process using supercritical fluids
US6221300B1 (en) * 1997-02-17 2001-04-24 Doppel Co., Ltd. Method for manufacturing artificial stone
GB9800936D0 (en) 1997-05-10 1998-03-11 Univ Nottingham Biofunctional polymers
DE69841422D1 (de) 1997-10-15 2010-02-11 Univ South Florida Beschichtung von partikelmaterial mittels superkritischer flüssigkeit
IT1296464B1 (it) * 1997-11-19 1999-06-25 Vectorpharma Int Composizioni farmaceutiche in forma di polveri di polimeri reticolati caricati con farmaci e relativo processo di preparazione mediante
GB9814619D0 (en) 1998-07-06 1998-09-02 Cole Polytechnique Fudurale De Materials and methods relating to encapsulation
US6340722B1 (en) 1998-09-04 2002-01-22 The University Of Akron Polymerization, compatibilized blending, and particle size control of powder coatings in a supercritical fluid
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
GB9920558D0 (en) * 1999-08-31 1999-11-03 Bradford Particle Design Ltd Methods for particle formation and their products
US6372259B1 (en) * 1999-11-10 2002-04-16 University Of Iowa Research Foundation Palatable, sustained release drug granules
WO2002020624A1 (en) 2000-09-08 2002-03-14 Ferro Corporation Controlled-release pharmaceuticals prepared by supercritical fluid processing techniques
US6521258B1 (en) 2000-09-08 2003-02-18 Ferro Corporation Polymer matrices prepared by supercritical fluid processing techniques
AU2002310567B2 (en) 2001-05-30 2005-10-20 Csir Method of encapsulating an active substance

Also Published As

Publication number Publication date
GB2392619A (en) 2004-03-10
ITMI20021169A0 (it) 2002-05-30
EP1401404B1 (de) 2008-04-16
GB2392619B (en) 2004-10-20
NL1020706C2 (nl) 2003-04-28
ITMI20021169A1 (it) 2003-12-01
CN1512877A (zh) 2004-07-14
DE10296849T5 (de) 2004-04-29
ES2305250T3 (es) 2008-11-01
US7641917B2 (en) 2010-01-05
EP1401404A2 (de) 2004-03-31
JP4313196B2 (ja) 2009-08-12
JP2005502642A (ja) 2005-01-27
AU2002310567B2 (en) 2005-10-20
DE60226140T2 (de) 2009-05-07
ZA200309983B (en) 2005-01-26
WO2003013478A3 (en) 2003-05-30
CN1255099C (zh) 2006-05-10
WO2003013478A8 (en) 2003-04-03
CA2455208C (en) 2009-02-03
CA2455208A1 (en) 2003-02-20
CH695418A5 (de) 2006-05-15
GB0327381D0 (en) 2003-12-31
DK1401404T3 (da) 2008-08-11
FR2825292A1 (fr) 2002-12-06
NL1020706A1 (nl) 2002-12-03
CY1108199T1 (el) 2014-02-12
US20050112205A1 (en) 2005-05-26
WO2003013478A2 (en) 2003-02-20
ATE392203T1 (de) 2008-05-15
BR0210000A (pt) 2004-05-04
HK1066488A1 (en) 2005-03-24
FR2825292B1 (fr) 2006-06-09
PT1401404E (pt) 2008-07-23

Similar Documents

Publication Publication Date Title
ATE297196T1 (de) Verfahren zur herstellung von nanometer partikeln durch fliessbett- sprühtrocknung
WO2005098083A3 (en) Miniature microwave plasma torch application and method of use thereof
DE69905460D1 (de) Verfahren und vorrichtung zur herstellung von partikeln
DE60140625D1 (de) Verfahren zur herstellung von mikropartikeln
SE9801287D0 (sv) Incorporation of active substances in carrier matrixes
WO2002093132A3 (en) Method for manufacture of fine particles
ATE289531T1 (de) Verfahren und vorrichtung zum auftragen von fluiden
DE69823806D1 (de) Verfahren und vorrichtung zur herstellung von teilchen
ATE314055T1 (de) Zubereitungen enthaltend mikropartikel von wasserunlöslichen stoffen und verfahren zu deren herstellung
WO2000066189A3 (en) Medical device coating method and coated devices
AU2002211708A1 (en) Apparatus, methods and articles of manufacture for executing computerized transaction processes
MXPA04000201A (es) Metodo y aparato para preparar particulas.
DE60226140D1 (de) Verfahren zur verkapselung eines wirkstoffs
DE69426568D1 (de) Verfahren zur umhüllung von nanopartikeln oder -tröpfchen
DE69407996D1 (de) Vorrichtung und verfahren zur herstellung eines agglomerierten materials
WO2004103939A8 (en) Assay method and apparatus
ATE396711T1 (de) Verfahren zur dispersion von wasserlöslichen oder hydrophilen substanzen in einem unter überkritischem druck stehenden fluid
PT1572315E (pt) Aparelho e método para o isolamento de partículas produzidas como uma suspensão num fluido não-supercrítico
ATE334159T1 (de) Verfahren zur herstellung von gut in wasser redispergierbaren und mit wasser benetzbaren polymerisatpulvern
EE05101B1 (et) Seade ja meetod vedelike t””tlemiseks ultraheliga
FR2821778B1 (fr) Procede d'assemblage automatisee de structures volumineuses notamment aeronautiques, dispositifs et produit logiciel permettant de le mettre en oeuvre
SE0202360D0 (sv) System and method for improving the movement and discharge of material from vessels
ATE368451T1 (de) Verfahren zum überziehen von feststoffteilchen
BR0208035A (pt) Partìcula discreta, artigo abrasivo, e, método de preparação de uma partìcula discreta e de um artigo abrasivo
WO2006016981A3 (en) Production of porous materials by supercritical fluid processing

Legal Events

Date Code Title Description
8363 Opposition against the patent